Autopsy report · NCT01456143

Optical Imaging of Head and Neck Cancer

“PI left, study to be re-open with new PI, no planned data analysis”

The sponsor’s own words in the registry.

Life of this trial

• Registered 2 months before it started.
• Ran for about 2 years 7 months before it stopped.
• 33 participants enrolled.
• Results were posted on the registry 1 year 11 months after it ended.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

Sharmila Anandasabapathy, MD

Sponsor type

University, hospital or other

Conditions

Squamous Cell Carcinoma; Neoplasia; Head and Neck Cancer

Interventions

High Resolution Microendoscopy (HRME); Proflavine hemisulfate

Participants

33

Sites

1

Countries

United States

Trials that died the same way

• Demonstrating the Diagnostic Power of an Electronic Nose: Study on Exhaled Air Samples
  “no PI to continue the study” (75% match in meaning)
• Assessment of Primary and Metastatic Brain Tumor Hypoxia With Fluoromisonidazole, FDG and Water
  “PI retired, study closed” (72% match in meaning)
• Electrode Placement and Audiologic Outcomes With the Advanced Bionics HiFocus L23 Electrode
  “device under study complication-due to PI departure, study closed and will not reopen” (70% match in meaning)
• Yttrium-90 (TARE-Y90) in Children, Adolescents, and Young Adults With Liver Tumors
  “PI left organization and discontinued study” (69% match in meaning)
• Window of Opportunity Study of Topical Tranexamic Acid for Cutaneous Squamous Cell Carcinoma
  “Study not moving forward due to upcoming PI departure” (68% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.